Open AccessLow rates of adherence for tumor necrosis factor-α inhibitors in Crohn’s disease and rheumatoid arthritis: Results of a systematic review
Author(s) -
Herma H. Fidder,
Maartje Singendonk,
Mike van der Have,
Bas Oldenburg,
Martijn G.H. van Oijen
Publication year - 2013
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v19.i27.4344
Subject(s) - adalimumab , infliximab , medicine , etanercept , rheumatoid arthritis , tumor necrosis factor alpha , crohn's disease , tumor necrosis factor α , disease , gastroenterology
To investigate adherence rates in tumor necrosis factor-α (TNF-α)-inhibitors in Crohn's disease (CD) and rheumatoid arthritis (RA) by systematic review of medical literature.